Article info
PDFMyositis
In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy
- Correspondence to Professor Olivier Boyer, Faculty of Health, Pathophysiology, Autoimmunity, Neuromuscular Diseases and Regenerative Therapies Inserm U1234, Rouen F-76000, France; olivier.boyer{at}chu-rouen.fr
Citation
In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy
Publication history
- Received April 4, 2018
- Revised September 7, 2018
- Accepted September 15, 2018
- First published October 11, 2018.
Online issue publication
February 02, 2023
Article Versions
- Previous version (2 November 2019).
- Previous version (2 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.